TriSalus Life Sciences, Inc. (TLSI)

3.53 -0.10 (-2.75%) USD  |  NASDAQ  |  Oct 19, 16:00
3.53 0.00 (0.00%) After-Hours: 16:47
More

TriSalus Life Sciences EPS Diluted (Quarterly) : -0.1576 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.1576
March 31, 2026 0.0294
December 31, 2025 -0.2082
September 30, 2025 -0.9586
June 30, 2025 -0.2736
March 31, 2025 -0.3886
December 31, 2024 -0.3953
September 30, 2024 -0.1208
June 30, 2024 -0.2147
March 31, 2024 -0.6006
December 31, 2023 -1.568
September 30, 2023 -0.1429
Date Value
June 30, 2023 -0.6078
March 31, 2023 -0.5708
December 31, 2022 -75.01
September 30, 2022 -25.95
June 30, 2022 0.0764
March 31, 2022 0.0908
December 31, 2021 0.0927
September 30, 2021 0.0597
June 30, 2021 0.0121
March 31, 2021 -0.0119
September 30, 2020 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -9.187M
Revenue (Quarterly) 11.41M
Total Expenses (Quarterly) 20.59M
Enterprise Value 211.27M
Gross Profit Margin (Quarterly) 86.78%
Profit Margin (Quarterly) -80.54%
Earnings Yield -36.69%
Normalized Earnings Yield -39.14